Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
US9682957B2 · kind B2 · utility
5Cited by
24References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2016 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | Dec 15, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a compound of formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.